Global Ophthalmology Treatment Market Size, Status and Forecast 2020-2026

May 2020 | 97 pages | ID: G0F427C135C1EN
QYResearch

Abstracts

This report focuses on the global Ophthalmology Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Ophthalmology Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

• Allergan
• Aerie Pharmaceuticals
• Pfizer
• Valeant
• Bayer
• Genentech
• Novartis
• Regeneron
• Takeda
• Santen Pharmaceutical

Market segment by Type, the product can be split into

• Gels
• Eye Solutions
• Capsules & Tablets
• Eye Drops
• Ointments

Market segment by Application, split into

• Hospital
• Retail Pharmacy

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Ophthalmology Treatment status, future forecast, growth opportunity, key market and key players.
• To present the Ophthalmology Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Ophthalmology Treatment are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Ophthalmology Treatment Revenue
1.4 Market Analysis by Type
  1.4.1 Global Ophthalmology Treatment Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Gels
  1.4.3 Eye Solutions
  1.4.4 Capsules & Tablets
  1.4.5 Eye Drops
  1.4.6 Ointments
1.5 Market by Application
  1.5.1 Global Ophthalmology Treatment Market Share by Application: 2020 VS 2026
  1.5.2 Hospital
  1.5.3 Retail Pharmacy
1.6 Study Objectives
1.7 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Ophthalmology Treatment Market Perspective (2015-2026)
2.2 Ophthalmology Treatment Growth Trends by Regions
  2.2.1 Ophthalmology Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Ophthalmology Treatment Historic Market Share by Regions (2015-2020)
  2.2.3 Ophthalmology Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Ophthalmology Treatment Market Growth Strategy
  2.3.6 Primary Interviews with Key Ophthalmology Treatment Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Ophthalmology Treatment Players by Market Size
  3.1.1 Global Top Ophthalmology Treatment Players by Revenue (2015-2020)
  3.1.2 Global Ophthalmology Treatment Revenue Market Share by Players (2015-2020)
  3.1.3 Global Ophthalmology Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Ophthalmology Treatment Market Concentration Ratio
  3.2.1 Global Ophthalmology Treatment Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Ophthalmology Treatment Revenue in 2019
3.3 Ophthalmology Treatment Key Players Head office and Area Served
3.4 Key Players Ophthalmology Treatment Product Solution and Service
3.5 Date of Enter into Ophthalmology Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Ophthalmology Treatment Historic Market Size by Type (2015-2020)
4.2 Global Ophthalmology Treatment Forecasted Market Size by Type (2021-2026)

5 OPHTHALMOLOGY TREATMENT BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Ophthalmology Treatment Market Size by Application (2015-2020)
5.2 Global Ophthalmology Treatment Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Ophthalmology Treatment Market Size (2015-2020)
6.2 Ophthalmology Treatment Key Players in North America (2019-2020)
6.3 North America Ophthalmology Treatment Market Size by Type (2015-2020)
6.4 North America Ophthalmology Treatment Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Ophthalmology Treatment Market Size (2015-2020)
7.2 Ophthalmology Treatment Key Players in Europe (2019-2020)
7.3 Europe Ophthalmology Treatment Market Size by Type (2015-2020)
7.4 Europe Ophthalmology Treatment Market Size by Application (2015-2020)

8 CHINA

8.1 China Ophthalmology Treatment Market Size (2015-2020)
8.2 Ophthalmology Treatment Key Players in China (2019-2020)
8.3 China Ophthalmology Treatment Market Size by Type (2015-2020)
8.4 China Ophthalmology Treatment Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Ophthalmology Treatment Market Size (2015-2020)
9.2 Ophthalmology Treatment Key Players in Japan (2019-2020)
9.3 Japan Ophthalmology Treatment Market Size by Type (2015-2020)
9.4 Japan Ophthalmology Treatment Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Ophthalmology Treatment Market Size (2015-2020)
10.2 Ophthalmology Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Ophthalmology Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Ophthalmology Treatment Market Size by Application (2015-2020)

11 INDIA

11.1 India Ophthalmology Treatment Market Size (2015-2020)
11.2 Ophthalmology Treatment Key Players in India (2019-2020)
11.3 India Ophthalmology Treatment Market Size by Type (2015-2020)
11.4 India Ophthalmology Treatment Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Ophthalmology Treatment Market Size (2015-2020)
12.2 Ophthalmology Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Ophthalmology Treatment Market Size by Type (2015-2020)
12.4 Central & South America Ophthalmology Treatment Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Allergan
  13.1.1 Allergan Company Details
  13.1.2 Allergan Business Overview and Its Total Revenue
  13.1.3 Allergan Ophthalmology Treatment Introduction
  13.1.4 Allergan Revenue in Ophthalmology Treatment Business (2015-2020))
  13.1.5 Allergan Recent Development
13.2 Aerie Pharmaceuticals
  13.2.1 Aerie Pharmaceuticals Company Details
  13.2.2 Aerie Pharmaceuticals Business Overview and Its Total Revenue
  13.2.3 Aerie Pharmaceuticals Ophthalmology Treatment Introduction
  13.2.4 Aerie Pharmaceuticals Revenue in Ophthalmology Treatment Business (2015-2020)
  13.2.5 Aerie Pharmaceuticals Recent Development
13.3 Pfizer
  13.3.1 Pfizer Company Details
  13.3.2 Pfizer Business Overview and Its Total Revenue
  13.3.3 Pfizer Ophthalmology Treatment Introduction
  13.3.4 Pfizer Revenue in Ophthalmology Treatment Business (2015-2020)
  13.3.5 Pfizer Recent Development
13.4 Valeant
  13.4.1 Valeant Company Details
  13.4.2 Valeant Business Overview and Its Total Revenue
  13.4.3 Valeant Ophthalmology Treatment Introduction
  13.4.4 Valeant Revenue in Ophthalmology Treatment Business (2015-2020)
  13.4.5 Valeant Recent Development
13.5 Bayer
  13.5.1 Bayer Company Details
  13.5.2 Bayer Business Overview and Its Total Revenue
  13.5.3 Bayer Ophthalmology Treatment Introduction
  13.5.4 Bayer Revenue in Ophthalmology Treatment Business (2015-2020)
  13.5.5 Bayer Recent Development
13.6 Genentech
  13.6.1 Genentech Company Details
  13.6.2 Genentech Business Overview and Its Total Revenue
  13.6.3 Genentech Ophthalmology Treatment Introduction
  13.6.4 Genentech Revenue in Ophthalmology Treatment Business (2015-2020)
  13.6.5 Genentech Recent Development
13.7 Novartis
  13.7.1 Novartis Company Details
  13.7.2 Novartis Business Overview and Its Total Revenue
  13.7.3 Novartis Ophthalmology Treatment Introduction
  13.7.4 Novartis Revenue in Ophthalmology Treatment Business (2015-2020)
  13.7.5 Novartis Recent Development
13.8 Regeneron
  13.8.1 Regeneron Company Details
  13.8.2 Regeneron Business Overview and Its Total Revenue
  13.8.3 Regeneron Ophthalmology Treatment Introduction
  13.8.4 Regeneron Revenue in Ophthalmology Treatment Business (2015-2020)
  13.8.5 Regeneron Recent Development
13.9 Takeda
  13.9.1 Takeda Company Details
  13.9.2 Takeda Business Overview and Its Total Revenue
  13.9.3 Takeda Ophthalmology Treatment Introduction
  13.9.4 Takeda Revenue in Ophthalmology Treatment Business (2015-2020)
  13.9.5 Takeda Recent Development
13.10 Santen Pharmaceutical
  13.10.1 Santen Pharmaceutical Company Details
  13.10.2 Santen Pharmaceutical Business Overview and Its Total Revenue
  13.10.3 Santen Pharmaceutical Ophthalmology Treatment Introduction
  13.10.4 Santen Pharmaceutical Revenue in Ophthalmology Treatment Business (2015-2020)
  13.10.5 Santen Pharmaceutical Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Ophthalmology Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Ophthalmology Treatment Revenue
Table 3. Ranking of Global Top Ophthalmology Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Ophthalmology Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Gels
Table 6. Key Players of Eye Solutions
Table 7. Key Players of Capsules & Tablets
Table 8. Key Players of Eye Drops
Table 9. Key Players of Ointments
Table 10. Global Ophthalmology Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Ophthalmology Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Ophthalmology Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Ophthalmology Treatment Market Share by Regions (2015-2020)
Table 14. Global Ophthalmology Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Ophthalmology Treatment Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Ophthalmology Treatment Market Growth Strategy
Table 20. Main Points Interviewed from Key Ophthalmology Treatment Players
Table 21. Global Ophthalmology Treatment Revenue by Players (2015-2020) (Million US$)
Table 22. Global Ophthalmology Treatment Market Share by Players (2015-2020)
Table 23. Global Top Ophthalmology Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ophthalmology Treatment as of 2019)
Table 24. Global Ophthalmology Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Ophthalmology Treatment Product Solution and Service
Table 27. Date of Enter into Ophthalmology Treatment Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Ophthalmology Treatment Market Size by Type (2015-2020) (Million US$)
Table 30. Global Ophthalmology Treatment Market Size Share by Type (2015-2020)
Table 31. Global Ophthalmology Treatment Revenue Market Share by Type (2021-2026)
Table 32. Global Ophthalmology Treatment Market Size Share by Application (2015-2020)
Table 33. Global Ophthalmology Treatment Market Size by Application (2015-2020) (Million US$)
Table 34. Global Ophthalmology Treatment Market Size Share by Application (2021-2026)
Table 35. North America Key Players Ophthalmology Treatment Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Ophthalmology Treatment Market Share (2019-2020)
Table 37. North America Ophthalmology Treatment Market Size by Type (2015-2020) (Million US$)
Table 38. North America Ophthalmology Treatment Market Share by Type (2015-2020)
Table 39. North America Ophthalmology Treatment Market Size by Application (2015-2020) (Million US$)
Table 40. North America Ophthalmology Treatment Market Share by Application (2015-2020)
Table 41. Europe Key Players Ophthalmology Treatment Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Ophthalmology Treatment Market Share (2019-2020)
Table 43. Europe Ophthalmology Treatment Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Ophthalmology Treatment Market Share by Type (2015-2020)
Table 45. Europe Ophthalmology Treatment Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Ophthalmology Treatment Market Share by Application (2015-2020)
Table 47. China Key Players Ophthalmology Treatment Revenue (2019-2020) (Million US$)
Table 48. China Key Players Ophthalmology Treatment Market Share (2019-2020)
Table 49. China Ophthalmology Treatment Market Size by Type (2015-2020) (Million US$)
Table 50. China Ophthalmology Treatment Market Share by Type (2015-2020)
Table 51. China Ophthalmology Treatment Market Size by Application (2015-2020) (Million US$)
Table 52. China Ophthalmology Treatment Market Share by Application (2015-2020)
Table 53. Japan Key Players Ophthalmology Treatment Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Ophthalmology Treatment Market Share (2019-2020)
Table 55. Japan Ophthalmology Treatment Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Ophthalmology Treatment Market Share by Type (2015-2020)
Table 57. Japan Ophthalmology Treatment Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Ophthalmology Treatment Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Ophthalmology Treatment Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Ophthalmology Treatment Market Share (2019-2020)
Table 61. Southeast Asia Ophthalmology Treatment Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Ophthalmology Treatment Market Share by Type (2015-2020)
Table 63. Southeast Asia Ophthalmology Treatment Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Ophthalmology Treatment Market Share by Application (2015-2020)
Table 65. India Key Players Ophthalmology Treatment Revenue (2019-2020) (Million US$)
Table 66. India Key Players Ophthalmology Treatment Market Share (2019-2020)
Table 67. India Ophthalmology Treatment Market Size by Type (2015-2020) (Million US$)
Table 68. India Ophthalmology Treatment Market Share by Type (2015-2020)
Table 69. India Ophthalmology Treatment Market Size by Application (2015-2020) (Million US$)
Table 70. India Ophthalmology Treatment Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Ophthalmology Treatment Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Ophthalmology Treatment Market Share (2019-2020)
Table 73. Central & South America Ophthalmology Treatment Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Ophthalmology Treatment Market Share by Type (2015-2020)
Table 75. Central & South America Ophthalmology Treatment Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Ophthalmology Treatment Market Share by Application (2015-2020)
Table 77. Allergan Company Details
Table 78. Allergan Business Overview
Table 79. Allergan Product
Table 80. Allergan Revenue in Ophthalmology Treatment Business (2015-2020) (Million US$)
Table 81. Allergan Recent Development
Table 82. Aerie Pharmaceuticals Company Details
Table 83. Aerie Pharmaceuticals Business Overview
Table 84. Aerie Pharmaceuticals Product
Table 85. Aerie Pharmaceuticals Revenue in Ophthalmology Treatment Business (2015-2020) (Million US$)
Table 86. Aerie Pharmaceuticals Recent Development
Table 87. Pfizer Company Details
Table 88. Pfizer Business Overview
Table 89. Pfizer Product
Table 90. Pfizer Revenue in Ophthalmology Treatment Business (2015-2020) (Million US$)
Table 91. Pfizer Recent Development
Table 92. Valeant Company Details
Table 93. Valeant Business Overview
Table 94. Valeant Product
Table 95. Valeant Revenue in Ophthalmology Treatment Business (2015-2020) (Million US$)
Table 96. Valeant Recent Development
Table 97. Bayer Company Details
Table 98. Bayer Business Overview
Table 99. Bayer Product
Table 100. Bayer Revenue in Ophthalmology Treatment Business (2015-2020) (Million US$)
Table 101. Bayer Recent Development
Table 102. Genentech Company Details
Table 103. Genentech Business Overview
Table 104. Genentech Product
Table 105. Genentech Revenue in Ophthalmology Treatment Business (2015-2020) (Million US$)
Table 106. Genentech Recent Development
Table 107. Novartis Company Details
Table 108. Novartis Business Overview
Table 109. Novartis Product
Table 110. Novartis Revenue in Ophthalmology Treatment Business (2015-2020) (Million US$)
Table 111. Novartis Recent Development
Table 112. Regeneron Business Overview
Table 113. Regeneron Product
Table 114. Regeneron Company Details
Table 115. Regeneron Revenue in Ophthalmology Treatment Business (2015-2020) (Million US$)
Table 116. Regeneron Recent Development
Table 117. Takeda Company Details
Table 118. Takeda Business Overview
Table 119. Takeda Product
Table 120. Takeda Revenue in Ophthalmology Treatment Business (2015-2020) (Million US$)
Table 121. Takeda Recent Development
Table 122. Santen Pharmaceutical Company Details
Table 123. Santen Pharmaceutical Business Overview
Table 124. Santen Pharmaceutical Product
Table 125. Santen Pharmaceutical Revenue in Ophthalmology Treatment Business (2015-2020) (Million US$)
Table 126. Santen Pharmaceutical Recent Development
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Ophthalmology Treatment Market Share by Type: 2020 VS 2026
Figure 2. Gels Features
Figure 3. Eye Solutions Features
Figure 4. Capsules & Tablets Features
Figure 5. Eye Drops Features
Figure 6. Ointments Features
Figure 7. Global Ophthalmology Treatment Market Share by Application: 2020 VS 2026
Figure 8. Hospital Case Studies
Figure 9. Retail Pharmacy Case Studies
Figure 10. Ophthalmology Treatment Report Years Considered
Figure 11. Global Ophthalmology Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Ophthalmology Treatment Market Share by Regions: 2020 VS 2026
Figure 13. Global Ophthalmology Treatment Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Ophthalmology Treatment Market Share by Players in 2019
Figure 16. Global Top Ophthalmology Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ophthalmology Treatment as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Ophthalmology Treatment Revenue in 2019
Figure 18. North America Ophthalmology Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Ophthalmology Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Ophthalmology Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Ophthalmology Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Ophthalmology Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Ophthalmology Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Ophthalmology Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Allergan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Allergan Revenue Growth Rate in Ophthalmology Treatment Business (2015-2020)
Figure 27. Aerie Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Aerie Pharmaceuticals Revenue Growth Rate in Ophthalmology Treatment Business (2015-2020)
Figure 29. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Pfizer Revenue Growth Rate in Ophthalmology Treatment Business (2015-2020)
Figure 31. Valeant Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Valeant Revenue Growth Rate in Ophthalmology Treatment Business (2015-2020)
Figure 33. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Bayer Revenue Growth Rate in Ophthalmology Treatment Business (2015-2020)
Figure 35. Genentech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Genentech Revenue Growth Rate in Ophthalmology Treatment Business (2015-2020)
Figure 37. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Novartis Revenue Growth Rate in Ophthalmology Treatment Business (2015-2020)
Figure 39. Regeneron Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Regeneron Revenue Growth Rate in Ophthalmology Treatment Business (2015-2020)
Figure 41. Takeda Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Takeda Revenue Growth Rate in Ophthalmology Treatment Business (2015-2020)
Figure 43. Santen Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Santen Pharmaceutical Revenue Growth Rate in Ophthalmology Treatment Business (2015-2020)
Figure 45. Bottom-up and Top-down Approaches for This Report
Figure 46. Data Triangulation
Figure 47. Key Executives Interviewed